American Psychiatric Association (2013) The Diagnostic and Statistical Manual of Mental Disorders (5th edn). American Psychiatric Publishing.Google Scholar

Bishop, K. M., Hogan, M., Janicki, M. et al. (2015) Guidelines for dementia-related health advocacy for adults with intellectual disability and dementia: National Task Group on Intellectual Disabilities and Dementia Practices. Intellectual and Developmental Disabilities, 53, 2–29.Google Scholar

British Psychological Society (2015) Dementia and People with Intellectual Disabilities: Guidance on the Assessment, Diagnosis, Interventions and Support of People with Intellectual Disabilities Who Develop Dementia. British Psychological Society.Google Scholar

Cleary, J. & Doody, O. (2016) Professional carers’ experiences of caring for individuals with intellectual disability and dementia: A review of the literature. Journal of Intellectual Disability. Epub, 14 March.Google Scholar

Cooper, S-A. (1997) High prevalence of dementia among people with learning disabilities not attributable to Down’s syndrome. Psychological Medicine, 27, 609–16.Google Scholar

Cosgrave, M. P., Tyrrell, J., McCarron, M. et al. (2000) A five year follow-up study of dementia in persons with Down’s syndrome: Early symptoms and patterns of deterioration. Irish Journal of Psychological Medicine, 17, 5–11.Google Scholar

Douglas, S., James, I. & Ballard, C (2004) Non-pharmacological interventions in dementia. Advances in Psychiatric Treatment, 10, 171–7.Google Scholar

Eady, N, Courtenay, K. & Strydom, A. (2015) Pharmacological management of behavioral and psychiatric symptoms in older adults with intellectual disability. Drugs Aging, 32, 95–102.Google Scholar

Evans, E., Bhardwaj, A., Brodaty, H. et al. (2013) Dementia in people with intellectual disability: Insights and challenges in epidemiological research with an at-risk population. International Review of Psychiatry, 25, 755–63.Google Scholar

Hanney, M., Prasher, V., Williams, N. et al. (2012) Memantine for dementia in adults older than 40 years with Down’s syndrome (MEADOWS): A randomised, double-blind, placebo-controlled trial. The Lancet, 379, 528–36.Google Scholar

Hartley, D., Blumenthal, T., Carrillo, M. et al. (2015) Down syndrome and Alzheimer’s disease: Common pathways, common goals. Alzheimer’s & Dementia, 11, 700–9. Epub, 12 December.Google Scholar

Holland, A. J., Hon, J., Huppert, F. A. et al. (2000) Incidence and course of dementia in people with Down’s syndrome: Findings from a population based-study. Journal of Intellectual Disability Research, 44, 138–46.Google Scholar

Janicki, M. P. & Dalton, A. J. (eds) (1999) Aging, Dementia and Intellectual Disabilities: A Handbook. Taylor & Francis.Google Scholar

Johnson, N., Fahey, C., Chicoine, B. et al. (2003) Effects of donepezil on cognitive functioning in Down syndrome. American Journal of Mental Retardation, 108, 367–72.Google Scholar

Kalsy-Lillico, S., Adams, D. & Oliver, C. (2012) Older adults with intellectual disabilities: issues in ageing and dementia. In Clinical Psychology and People with Intellectual Disabilities (2nd edn) (eds. Emerson, E., Hatton, C., Dickson, K., Gone, R., Caine, A. & Bromley, J.). Wiley.Google Scholar

Kerr, M. P., Turky, A. & Huber, B. (2009) The psychosocial impact of epilepsy in adults in adults with an intellectual disability. Epilepsy and Behaviour, 15 (suppl. 1), S26–3.Google Scholar

Kishnani, P. S., Sommer, B. R., Handen, B. L. et al. (2009) The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome. American Journal of Medical Genetics Part A, 149A, 1641–54.Google Scholar

Lavigna, G. W. & Willis, T. J. (2012) The efficacy of positive behavioural support with the most challenging behaviour: The evidence and its implications. Journal of Intellectual and Developmental Disability, 37, 185–95.Google Scholar

Lott, I. T., Doran, E., Nguyen, V. Q. et al. (2012) Down syndrome and dementia: Seizures and cognitive decline. Journal of Alzheimer's Disease, 29, 177–85.Google Scholar

Lott, I. T., Osann, K., Doran, E. et al. (2002) Down syndrome and Alzheimer disease: Response to donepezil. Archives of Neurology, 59, 1133–6.Google Scholar

McCarron, M., Gill, M., McCallion, P. et al. (2005) Health co-morbidities in ageing persons with Down syndrome and Alzheimer’s dementia.Journal of Intellectual Disability Research, 49, 560–6.Google Scholar

McCarron, M., McCallion, P., Reilly, E. et al. (2014) A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome. Journal of Intellectual Disability Research, 58, 61–70.Google Scholar

Marshall, M. (1998) How it helps to see dementia as a disability. Journal of Dementia Care, 6, 15–17.Google Scholar

Mohan, M., Bennett, C. & Carpenter, P. K. (2009a) Memantine for dementia in people with Down syndrome. Cochrane Database of Systematic Reviews, (1), CD007657.Google Scholar

Mohan, M., Bennett, C. & Carpenter, P. K. (2009b) Galantamine for dementia in people with Down syndrome. Cochrane Database of Systematic Reviews, (1), CD007656.Google Scholar

Mohan, M., Bennett, C. & Carpenter, P. K.(2009c) Rivastigmine for dementia in people with Down syndrome. Cochrane Database of Systematic Reviews, (1), CD007658.Google Scholar

Mohan, M., Carpenter, P. K., Bennett, C. (2009d) Donepezil for dementia in people with Down syndrome. Cochrane Database of Systematic Reviews, (1), CD007178.Google Scholar

Moran, J. A., Rafii, M. S., Keller, S. M. et al. (2013) The National Task Group on Intellectual Disabilities and Dementia Practices consensus recommendations for the evaluation and management of dementia in adults with intellectual disabilities. Mayo Clinic Proceedings, 88, 831–40.Google Scholar

Nagdee, M. (2011) Dementia in intellectual disability: A review of diagnostic challenges. African Journal of Psychiatry, 14, 194–9.Google Scholar

NICE [National Institute of Health and Care Excellence] (2006) [webpage] Dementia: Supporting people with dementia and their carers in health and social care. clinical guidelines. CG42. Available at: www.nice.org.uk/CG42 [accessed 11 August 2018]Google Scholar

Nieuwenhuis-Mark, R. (2009) Diagnosing Alzheimer’s dementia in Down syndrome: Problems and possible solutions. Research in Developmental Disabilities, 30, 827–38.Google Scholar

Oliver, C. & Holland, A. J. (1986) Down’s syndrome and Alzheimer’s disease: A review. Psychological Medicine, 16, 307–22.Google Scholar

Prasher, V. P. (1995) Age specific prevalence, thyroid dysfunction and depressive symptomatology in adults with down syndrome and dementia. International Journal of Geriatric Psychiatry, 10, 25–31.Google Scholar

Prasher, V. P. (2005) Alzheimer’s Disease, Dementia, Down Syndrome and Intellectual Disabilities. Radcliffe Press.Google Scholar

Prasher, V. P. (2014) Practical Dementia Care for Adults with Down Syndrome or with Intellectual Disabilities. Nova Science.Google Scholar

Prasher, V. P. & Corbett, J. A. (1993) Onset of seizures as a poor indicator of longevity in people with Down syndrome and dementia. International Journal of Geriatric Psychiatry, 8, 922–7.Google Scholar

Prasher, V. P., Cumella, S., Natarajan, K. et al. (2003) Magnetic resonance imaging, Down’s syndrome and Alzheimer’s disease: research and clinical implications. Journal of Intellectual Disability Research, 47 (part 2), 90–100.Google Scholar

Prasher, V. P., Mahmood, H. & Mitra, M. (2016) Challenges faced in managing dementia in Alzheimer’s disease in patients with Down syndrome. Degenerative Neurological and Neuromuscular Disease, 6, 85–94.Google Scholar

Prasher, V. P., Sachdeva, N., Adams, C. et al. (2013) Rivastigmine transdermal patches in the treatment of dementia in Alzheimer’s disease in adults with Down syndrome: Pilot study. International Journal of Geriatric Psychiatry, 28, 219–20.Google Scholar

Prasher, V. P., Sachdeva, N. & Tarrant, N. (2015) Diagnosing dementia in adults with Down’s syndrome. Neurodegenerative Disease Management, 5, 249–56.Google Scholar

Pueschel, S. M., Louis, S. & McKnight, P. (1991) Seizure disorders in Down syndrome. Archives of Neurology, 48, 318–20.Google Scholar

Strydom, A., Chan, T., King, M. et al. (2013) Incidence of dementia in older adults with intellectual disabilities. Research in Developmental Disabilities, 34, 1881–5.Google Scholar

Strydom, A., Hassoitis, A., King, M. et al. (2009) The relationship of dementia prevalence in older adults with intellectual disability (ID) to age and severity of ID. Psychological Medicine, 39, 13–21.Google Scholar

Tsiouris, J. A., Patti, P. J. & Flory, M. J. (2014) Effects of antidepressants on longevity and dementia onset among adults with Down syndrome: A retrospective study. Degenerative Neurological and Neuromuscular Disease, 75, 731–7.Google Scholar

Wark, S., Hussain, R. & Parmenter, T. (2014) Down syndrome and dementia: Is depression a confounder for accurate diagnosis and treatment? Journal of Intellect Disabilities, 18, 305–14.Google Scholar

World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines.Google Scholar

Zeilinger, E. L., Stiehl, K. A. & Weber, G. (2013) A systematic review on assessment instruments for dementia in persons with intellectual disabilities. Research in Developmental Disabilities, 34, 3962–77.Google Scholar

Zigman, W. B., Schupf, N., Devenny, D. A. et al. (2004) Incidence and prevalence of dementia in elderly adults with mental retardation without Down syndrome. American Journal on Mental Retardation, 109, 126–41.Google Scholar